Status:

TERMINATED

Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis

Lead Sponsor:

Dr. Falk Pharma GmbH

Conditions:

Radiation Proctitis

Eligibility:

MALE

18+ years

Phase:

PHASE2

Brief Summary

To proof the superiority of an 8-week rectal treatment with once-daily 2 mg budesonide versus placebo for the prevention of acute radiation proctitis, and to evaluate the occurrence of chronic radiati...

Eligibility Criteria

Inclusion

  • Signed informed consent,
  • Men aged at least 18 years,
  • Patients with ECOG performance status \<= 2 or Karnofsky Performance Status Scale \>= 70%,
  • Estimated life expectancy more than 3 years,
  • Diagnosis of prostate carcinoma,
  • Indication for local RT in patients with prostatic cancer.

Exclusion

  • Crohn's disease, indeterminate colitis, ulcerative colitis, microscopic colitis (i.e., collagenous colitis and lymphocytic colitis),
  • Severe or symptomatic ischaemic colitis at baseline,
  • Grade III internal haemorrhoids at baseline,
  • High risk patients needing extended radiation therapy,
  • Acute EORTC/RTOG lower GI toxicity score of \>=1 at baseline,
  • Bacterial, amoebic, fungal, or viral infections of the gut,
  • Tuberculosis, hypertension, infection, diabetes mellitus (included familiarly predisposition), active peptic ulcer, osteoporosis, glaucoma, or cataract, if careful medical monitoring is not ensured,
  • Portal hypertension or liver cirrhosis,
  • Abnormal hepatic function (ALT, AST or AP \> 2.5 x ULN),
  • Known intolerance/hypersensitivity/resistance to study drug or drugs of similar chemical structure or pharmacological profile, or to any of the other constituents of the study drug,
  • Participation in another clinical trial within the last 30 days, simultaneous participation in another clinical trial, or previous participation in this trial

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT00828230

Start Date

September 1 2008

End Date

October 1 2011

Last Update

January 30 2012

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Klinik für Radioonkologie und Strahlentherapie - Klinikum Braunschweig

Braunschweig, Germany, 38114

2

Strahlentherapie, St. Vincentius-Kliniken gAG

Karlsruhe, Germany, 76135

3

Strahlentherapie, Klinikum Mutterhaus der Borromäerinnen

Trier, Germany, 54290